Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 462

1.

Central hypothyroidism - a neglected thyroid disorder.

Beck-Peccoz P, Rodari G, Giavoli C, Lania A.

Nat Rev Endocrinol. 2017 May 26. doi: 10.1038/nrendo.2017.47. [Epub ahead of print] Review.

PMID:
28549061
2.

Focus on GH deficiency and thyroid function.

Giavoli C, Profka E, Rodari G, Lania A, Beck-Peccoz P.

Best Pract Res Clin Endocrinol Metab. 2017 Feb;31(1):71-78. doi: 10.1016/j.beem.2017.02.003. Epub 2017 Feb 24. Review.

PMID:
28477734
3.

Erratum to: Long-term safety and efficacy of Omnitrope® in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study.

Ferone D, Profka E, Gasco V, Ambrosio MR, Colao A, Di Somma C, Puxeddu E, Arnaldi G, Pagano C, Zecchi E, Pietropoli A, Beck-Peccoz P.

J Endocrinol Invest. 2017 Jun;40(6):679-681. doi: 10.1007/s40618-017-0664-4. No abstract available.

PMID:
28421564
4.

Retinal photoreceptor functions are compromised in patients with resistance to thyroid hormone syndrome (RTHβ).

Campi I, Cammarata G, Bianchi Marzoli S, Beck-Peccoz P, Santarsiero D, Dazzi D, Bottari de Castello A, Taroni EG, Viola F, Mian C, Watuntantrige-Fernando S, Pelusi C, Muzza M, Maffini MA, Persani L.

J Clin Endocrinol Metab. 2017 Mar 31. doi: 10.1210/jc.2016-3671. [Epub ahead of print]

PMID:
28379567
5.

Long-term safety and efficacy of Omnitrope® in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study.

Ferone D, Profka E, Gasco V, Ambrosio MR, Colao A, Di Somma C, Puxeddu E, Arnaldi G, Pagano C, Zecchi E, Pietropoli A, Beck-Peccoz P.

J Endocrinol Invest. 2017 Jun;40(6):669-678. doi: 10.1007/s40618-016-0604-8. Epub 2017 Feb 4. Erratum in: J Endocrinol Invest. 2017 Jun;40(6):679-681.

6.

Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database.

Giusti F, Cianferotti L, Boaretto F, Cetani F, Cioppi F, Colao A, Davì MV, Faggiano A, Fanciulli G, Ferolla P, Ferone D, Fossi C, Giudici F, Gronchi G, Loli P, Mantero F, Marcocci C, Marini F, Masi L, Opocher G, Beck-Peccoz P, Persani L, Scillitani A, Sciortino G, Spada A, Tomassetti P, Tonelli F, Brandi ML.

Endocrine. 2017 Jan 28. doi: 10.1007/s12020-017-1234-4. [Epub ahead of print]

PMID:
28132167
7.

Analysis of BCLI, N363S and ER22/23EK Polymorphisms of the Glucocorticoid Receptor Gene in Adrenal Incidentalomas.

Reimondo G, Chiodini I, Puglisi S, Pia A, Morelli V, Kastelan D, Cannavo S, Berchialla P, Giachino D, Perotti P, Cuccurullo A, Paccotti P, Beck-Peccoz P, De Marchi M, Terzolo M.

PLoS One. 2016 Sep 20;11(9):e0162437. doi: 10.1371/journal.pone.0162437. eCollection 2016.

8.

Longitudinal behavior of autoimmune GH deficiency: from childhood to transition age.

De Bellis A, Bellastella G, Maiorino MI, Aitella E, Lucci E, Cozzolino D, Bellastella A, Bizzarro A, Giugliano D, Esposito K; Italian Autoimmune Hypophysitis Network Group.

Eur J Endocrinol. 2016 Mar;174(3):381-7. doi: 10.1530/EJE-15-0766. Epub 2015 Nov 23.

9.

The activity of 11β-hydroxysteroid dehydrogenase type 2 enzyme and cortisol secretion in patients with adrenal incidentalomas.

Morelli V, Polledri E, Mercadante R, Zhukouskaya V, Palmieri S, Beck-Peccoz P, Spada A, Fustinoni S, Chiodini I.

Endocrine. 2016 Sep;53(3):809-15. doi: 10.1007/s12020-015-0763-y. Epub 2015 Oct 5.

PMID:
26438395
10.

Preface.

Beck-Peccoz P.

Best Pract Res Clin Endocrinol Metab. 2015 Aug;29(4):515-6. doi: 10.1016/j.beem.2015.07.006. Epub 2015 Jul 23. No abstract available.

PMID:
26303079
11.

B Cell Activating Factor (BAFF) and BAFF Receptor Expression in Autoimmune and Nonautoimmune Thyroid Diseases.

Campi I, Tosi D, Rossi S, Vannucchi G, Covelli D, Colombo F, Trombetta E, Porretti L, Vicentini L, Cantoni G, Currò N, Beck-Peccoz P, Bulfamante G, Salvi M.

Thyroid. 2015 Sep;25(9):1043-9. doi: 10.1089/thy.2015.0029. Epub 2015 Aug 13.

PMID:
26214745
12.

Characteristics and outcomes of Italian patients from the observational, multicentre, hypopituitary control and complications study (HypoCCS) according to tertiles of growth hormone peak concentration following stimulation testing at study entry.

Losa M, Beck-Peccoz P, Aimaretti G, Di Somma C, Ambrosio MR, Ferone D, Giampietro A, Corsello SM, Poggi M, Scaroni C, Jia N, Mossetto G, Cannavò S, Rochira V.

Clin Endocrinol (Oxf). 2015 Oct;83(4):527-35. doi: 10.1111/cen.12839. Epub 2015 Jul 31.

PMID:
26119712
13.

Hypothalamic-Pituitary Axis in Non-Functioning Pituitary Adenomas: Focus on the Prevalence of Isolated Central Hypoadrenalism.

Carosi G, Malchiodi E, Ferrante E, Sala E, Verrua E, Profka E, Giavoli C, Filopanti M, Beck-Peccoz P, Spada A, Mantovani G.

Neuroendocrinology. 2015;102(4):267-273. Epub 2015 Apr 29.

PMID:
25924873
14.

Thyrotropin-Secreting Pituitary Adenomas.

Beck-Peccoz P, Persani L, Lania A.

In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2015 May 1.

15.

Physiology of the Hypothalamic-Pituitary-Thyroid Axis.

Mariotti S, Beck-Peccoz P.

In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2016 Aug 14.

16.

Statins may increase the risk of liver dysfunction in patients treated with steroids for active graves' orbitopathy.

Covelli D, Vannucchi G, Campi I, Currò N, D'Ambrosio R, Maggioni M, Gianelli U, Beck-Peccoz P, Salvi M.

J Clin Endocrinol Metab. 2015 May;100(5):1731-7. doi: 10.1210/jc.2014-4463. Epub 2015 Mar 9.

PMID:
25751109
17.

Screening for ACTH-dependent hypercortisolism in patients affected with pituitary incidentaloma.

Toini A, Dolci A, Ferrante E, Verrua E, Malchiodi E, Sala E, Lania AG, Chiodini I, Beck-Peccoz P, Arosio M, Spada A, Mantovani G.

Eur J Endocrinol. 2015 Apr;172(4):363-9. doi: 10.1530/EJE-14-0599.

18.

Lipid abnormalities in patients with adrenal incidentalomas: role of subclinical hypercortisolism and impaired glucose metabolism.

Masserini B, Morelli V, Palmieri S, Eller-Vainicher C, Zhukouskaya V, Cairoli E, Orsi E, Beck-Peccoz P, Spada A, Chiodini I.

J Endocrinol Invest. 2015 Jun;38(6):623-8. doi: 10.1007/s40618-014-0232-0. Epub 2015 Jan 23.

PMID:
25608646
19.

Reevaluation of Acromegalic Patients in Long-Term Remission according to Newly Proposed Consensus Criteria for Control of Disease.

Verrua E, Ferrante E, Filopanti M, Malchiodi E, Sala E, Giavoli C, Arosio M, Lania AG, Ronchi CL, Mantovani G, Beck-Peccoz P, Spada A.

Int J Endocrinol. 2014;2014:581594. doi: 10.1155/2014/581594. Epub 2014 Dec 21.

20.

Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study.

Salvi M, Vannucchi G, Currò N, Campi I, Covelli D, Dazzi D, Simonetta S, Guastella C, Pignataro L, Avignone S, Beck-Peccoz P.

J Clin Endocrinol Metab. 2015 Feb;100(2):422-31. doi: 10.1210/jc.2014-3014. Epub 2014 Dec 15.

Supplemental Content

Loading ...
Support Center